Wang X, Ishimatsu K, Li J, Wen X, Ou W, Anwar A
Hepat Oncol. 2025; 11(1):2389031.
PMID: 39881558
PMC: 11407511.
DOI: 10.1080/20450923.2024.2389031.
Torres C, Mancinelli G, Chen J, Cordoba-Chacon J, Pins D, Saeed S
Nutrients. 2025; 17(1).
PMID: 39796583
PMC: 11722924.
DOI: 10.3390/nu17010150.
Cristani M, Citarella A, Carnamucio F, Micale N
Biomolecules. 2024; 14(8).
PMID: 39199418
PMC: 11352298.
DOI: 10.3390/biom14081031.
Ali A, Hachem M, Ahmmed M
Heliyon. 2024; 10(9):e30946.
PMID: 38774069
PMC: 11107210.
DOI: 10.1016/j.heliyon.2024.e30946.
Dai L, Li S, Hao Q, Zhou R, Zhou H, Lei W
Nanoscale Adv. 2023; 5(4):1011-1022.
PMID: 36798503
PMC: 9926902.
DOI: 10.1039/d2na00883a.
Iron as a therapeutic target in chronic liver disease.
Kouroumalis E, Tsomidis I, Voumvouraki A
World J Gastroenterol. 2023; 29(4):616-655.
PMID: 36742167
PMC: 9896614.
DOI: 10.3748/wjg.v29.i4.616.
Recent Development of LDL-Based Nanoparticles for Cancer Therapy.
He B, Yang Q
Pharmaceuticals (Basel). 2023; 16(1).
PMID: 36678515
PMC: 9863478.
DOI: 10.3390/ph16010018.
Repeated trans-arterial treatments of LDL-DHA nanoparticles induce multiple pathways of tumor cell death in hepatocellular carcinoma bearing rats.
Wang Y, Li J, Dias do Vale G, Chaudhary J, Anwar A, McDonald J
Front Oncol. 2022; 12:1052221.
PMID: 36505796
PMC: 9730405.
DOI: 10.3389/fonc.2022.1052221.
Crosstalk of low density lipoprotein and liposome as a paradigm for targeting of 5-fluorouracil into hepatic cells: cytotoxicity and liver deposition.
Alanazi S, Harisa G, Badran M, Alanazi F, Elzayat E, Alomrani A
Bioengineered. 2021; 12(1):914-926.
PMID: 33678142
PMC: 8806320.
DOI: 10.1080/21655979.2021.1896202.
Low-density lipoprotein nanomedicines: mechanisms of targeting, biology, and theranostic potential.
Di L, Maiseyeu A
Drug Deliv. 2021; 28(1):408-421.
PMID: 33594923
PMC: 7894439.
DOI: 10.1080/10717544.2021.1886199.
Assessing the safety of transarterial locoregional delivery of low-density lipoprotein docosahexaenoic acid nanoparticles to the rat liver.
Li J, Canseco D, Wang Y, Vale G, Chaudhary J, Anwar A
Eur J Pharm Biopharm. 2020; 158:273-283.
PMID: 33242579
PMC: 8121338.
DOI: 10.1016/j.ejpb.2020.10.018.
An implanted port-catheter system for repeated hepatic arterial infusion of low-density lipoprotein-docosahexaenoic acid nanoparticles in normal rats: A safety study.
Wang Y, Li J, Subramaniyan I, Dias do Vale G, Chaudhary J, Anwar A
Toxicol Appl Pharmacol. 2020; 400:115037.
PMID: 32417438
PMC: 7418948.
DOI: 10.1016/j.taap.2020.115037.
Nanomedicine-based formulations containing ω-3 polyunsaturated fatty acids: potential application in cardiovascular and neoplastic diseases.
Serini S, Cassano R, Trombino S, Calviello G
Int J Nanomedicine. 2019; 14:2809-2828.
PMID: 31114196
PMC: 6488162.
DOI: 10.2147/IJN.S197499.
Effects of low-density lipoprotein docosahexaenoic acid nanoparticles on cancer stem cells isolated from human hepatoma cell lines.
Yang J, Gong Y, Sontag D, Corbin I, Minuk G
Mol Biol Rep. 2018; 45(5):1023-1036.
PMID: 30069818
DOI: 10.1007/s11033-018-4252-2.
Low density lipoprotein modified silica nanoparticles loaded with docetaxel and thalidomide for effective chemotherapy of liver cancer.
Ao M, Xiao X, Ao Y
Braz J Med Biol Res. 2018; 51(3):1-10.
PMID: 29513882
PMC: 5912100.
DOI: 10.1590/1414-431X20176650.
Biomimetics: reconstitution of low-density lipoprotein for targeted drug delivery and related theranostic applications.
Zhu C, Xia Y
Chem Soc Rev. 2017; 46(24):7668-7682.
PMID: 29104991
PMC: 5725233.
DOI: 10.1039/c7cs00492c.
Low-density lipoprotein docosahexaenoic acid nanoparticles induce ferroptotic cell death in hepatocellular carcinoma.
Ou W, Mulik R, Anwar A, McDonald J, He X, Corbin I
Free Radic Biol Med. 2017; 112:597-607.
PMID: 28893626
PMC: 5848495.
DOI: 10.1016/j.freeradbiomed.2017.09.002.
Elucidating the structural organization of a novel low-density lipoprotein nanoparticle reconstituted with docosahexaenoic acid.
Mulik R, Zheng H, Pichumani K, Ratnakar J, Jiang Q, Corbin I
Chem Phys Lipids. 2017; 204:65-75.
PMID: 28342772
PMC: 5477227.
DOI: 10.1016/j.chemphyslip.2017.03.007.
Cellular uptake mechanism and comparative evaluation of antineoplastic effects of paclitaxel-cholesterol lipid emulsion on triple-negative and non-triple-negative breast cancer cell lines.
Ye J, Xia X, Dong W, Hao H, Meng L, Yang Y
Int J Nanomedicine. 2016; 11:4125-40.
PMID: 27601899
PMC: 5003597.
DOI: 10.2147/IJN.S113638.
Investigation into the distinct subcellular effects of docosahexaenoic acid loaded low-density lipoprotein nanoparticles in normal and malignant murine liver cells.
Moss L, Mulik R, Treuren T, Kim S, Corbin I
Biochim Biophys Acta. 2016; 1860(11 Pt A):2363-2376.
PMID: 27418237
PMC: 5011002.
DOI: 10.1016/j.bbagen.2016.07.004.